X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
injections, intralesional (81) 81
index medicus (56) 56
animals (54) 54
female (43) 43
male (40) 40
mice (37) 37
oncology (28) 28
dermatology (24) 24
treatment outcome (24) 24
cancer (23) 23
care and treatment (22) 22
middle aged (22) 22
aged (21) 21
research (21) 21
medicine, research & experimental (20) 20
cell line, tumor (18) 18
adult (17) 17
expression (16) 16
mice, nude (15) 15
surgery (15) 15
therapy (14) 14
tumors (14) 14
gene expression (13) 13
health aspects (13) 13
biotechnology & applied microbiology (12) 12
gene therapy (12) 12
apoptosis (11) 11
dose-response relationship, drug (11) 11
genetics & heredity (11) 11
wound healing (11) 11
xenograft model antitumor assays (11) 11
biochemistry & molecular biology (10) 10
in-vivo (10) 10
wound healing - drug effects (10) 10
antineoplastic agents - administration & dosage (9) 9
disease models, animal (9) 9
otorhinolaryngology (9) 9
photodynamic therapy (9) 9
cells (8) 8
combined modality therapy (8) 8
drug therapy (8) 8
efficacy (8) 8
epidermal growth factor (8) 8
medicine (8) 8
skin (8) 8
skin cancer (8) 8
brain neoplasms - drug therapy (7) 7
breast cancer (7) 7
chemotherapy (7) 7
epidermal growth factor - administration & dosage (7) 7
follow-up studies (7) 7
glioma (7) 7
immunotherapy (7) 7
neoplasm transplantation (7) 7
research article (7) 7
squamous cell carcinoma (7) 7
studies (7) 7
tumor cells, cultured (7) 7
adenovirus (6) 6
antineoplastic agents - therapeutic use (6) 6
brain neoplasms - therapy (6) 6
carcinoma, squamous cell - drug therapy (6) 6
diabetic foot (6) 6
diabetic foot - drug therapy (6) 6
dosage and administration (6) 6
epidermal growth factor - therapeutic use (6) 6
epidermal-growth-factor (6) 6
genetic therapy - methods (6) 6
immunohistochemistry (6) 6
in-vitro (6) 6
intralesional cidofovir (6) 6
medical research (6) 6
pharmacology & pharmacy (6) 6
rats (6) 6
usage (6) 6
administration, topical (5) 5
aged, 80 and over (5) 5
antineoplastic agents - pharmacology (5) 5
cancer therapies (5) 5
carcinoma, squamous cell - pathology (5) 5
cell biology (5) 5
cell proliferation (5) 5
child (5) 5
cytokines (5) 5
diagnosis (5) 5
double-blind (5) 5
genetic aspects (5) 5
genetic vectors - administration & dosage (5) 5
glioblastoma (5) 5
glioma - drug therapy (5) 5
growth (5) 5
growth-factor (5) 5
human papillomavirus (5) 5
infections (5) 5
infusions, intralesional (5) 5
inhibition (5) 5
injections, intravenous (5) 5
keloids (5) 5
melanoma (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, ISSN 8750-7315, 01/2017, Volume 107, Issue 1, pp. 17 - 29
Background: Intralesional epidermal growth factor (EGF) has been available as a medication in Turkey since 2012. We present the results of our experience using... 
ULCERS | INFECTIONS | MULTICENTER | MANAGEMENT | CLOSURE | GRANULATION | ORTHOPEDICS | Humans | Middle Aged | Diabetic Foot - pathology | Male | Treatment Outcome | Epidermal Growth Factor - therapeutic use | Turkey | Injections, Intralesional | Amputation | Female | Aged | Retrospective Studies | Diabetic Foot - therapy
Journal Article
Turkish Journal of Medical Sciences, ISSN 1300-0144, 2017, Volume 47, Issue 5, pp. 1500 - 1504
Background/aim: Intralesional recombinant epidermal growth factor (EGF) is a new treatment approach for diabetic foot ulcer, approved in 2006. EGF therapy is... 
Wound healing | Diabetic foot | Intralesional epidermal growth factor | MEDICINE, GENERAL & INTERNAL | intralesional epidermal growth factor | wound healing
Journal Article
Journal Article
Journal Article
Diabetic Foot & Ankle, ISSN 2000-625X, 01/2015, Volume 6, Issue 1, pp. 28419 - 5
Journal Article
Journal Article
Journal Article
Human Gene Therapy, ISSN 1043-0342, 05/2012, Volume 23, Issue 5, pp. 484 - 491
Oncolytic vesicular stomatitis virus (VSV) has potent antitumor activity, but infects a broad range of cell types. Here, we used the measles virus (MV)... 
Research Articles | NONHUMAN-PRIMATES | FACTOR-RECEPTOR | STRAINS | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | CANCER | LENTIVIRAL VECTORS | THERAPY | TROPISM | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | EPIDERMAL-GROWTH-FACTOR | IN-VIVO | GENETICS & HEREDITY | Folate Receptor 1 - immunology | Cricetulus | Genetic Vectors - administration & dosage | Viral Fusion Proteins - genetics | Humans | Male | Recombinant Fusion Proteins | Measles virus - genetics | Neoplasms - therapy | Receptor, Epidermal Growth Factor - metabolism | Glutamate Carboxypeptidase II - metabolism | Single-Chain Antibodies - genetics | Injections, Intralesional | HEK293 Cells | Antigens, Surface - metabolism | Vesiculovirus - genetics | Female | CHO Cells | Glutamate Carboxypeptidase II - immunology | Receptor, Epidermal Growth Factor - immunology | Cricetinae | Green Fluorescent Proteins - analysis | Hemagglutinins, Viral - genetics | Mice, SCID | Oncolytic Virotherapy | Animals | Folate Receptor 1 - metabolism | Vesiculovirus - metabolism | Cell Line, Tumor | Mice | Antigens, Surface - immunology | Epidermal growth factor receptors | Antibodies | Immunoblotting | Glycoproteins | Tumor cell lines | Folic acid | Infection | Envelopes | Reporter gene | Measles | Virions | Green fluorescent protein | Xenografts | Hemagglutinins | Oncolysis | Antitumor activity | Gene therapy | Prostate | Tumors
Journal Article